The clinical trial for convalescent plasma therapy commenced at the Madras Medical College with the first donor — a patient who recovered from coronavirus disease (COVID-19) — coming forward to make the donation on Monday.
The Madras Medical College is part of the Indian Council of Medical Research’s multi-centre trial, and also obtained the approval for an institutional trial for severe COVID-19 patients.
“A patient who recovered from COVID-19 has donated plasma for the trial. With this, the approved clinical trial has commenced at MMC,” an official said.
Apart from the MMC, the ICMR has granted approval for Madurai Medical College, Tirunelveli Medical College and Christian Medical College, Vellore, for its multi-centre clinical trial.
You have reached your limit for free articles this month.
Register to The Hindu for free and get unlimited access for 30 days.
Subscription Benefits Include
Today's Paper
Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.
Unlimited Access
Enjoy reading as many articles as you wish without any limitations.
Personalised recommendations
A select list of articles that match your interests and tastes.
Faster pages
Move smoothly between articles as our pages load instantly.
Dashboard
A one-stop-shop for seeing the latest updates, and managing your preferences.
Briefing
We brief you on the latest and most important developments, three times a day.
Not convinced? Know why you should pay for news.
*Our Digital Subscription plans do not currently include the e-paper ,crossword, iPhone, iPad mobile applications and print. Our plans enhance your reading experience.
